Filing Details
- Accession Number:
- 0001213900-20-041813
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-09 16:30:29
- Reporting Period:
- 2020-12-07
- Accepted Time:
- 2020-12-09 16:30:29
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1733413 | Tff Pharmaceuticals Inc. | TFFP | Pharmaceutical Preparations (2834) | 824344737 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1790933 | Brian James Windsor | 2600 Via Fortuna, Suite 360 Austin TX 78746 | Chief Science Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-12-07 | 25,000 | $2.50 | 30,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-12-07 | 25,000 | $15.80 | 5,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (Right to Buy) | Disposition | 2020-12-07 | 25,000 | $0.00 | 25,000 | $2.50 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
134,429 | 2019-09-26 | 2028-09-26 | No | 4 | M | Direct |
Footnotes
- The transactions reported by this Form 4 reflect the Reporting Person's exercise of options to purchase common shares pursuant to Rule 16b-3 under the Securities Exchange Act of 1934 and the Reporting Person's concurrent sale of the common shares acquired upon the exercise of the options.
- 18,003 shares of common stock vested on September 26, 2019 and the remainder of the shares vested at an approximate rate of 4,500 every three months thereafter.